Research priorities to reduce the impact of COVID-19 in low- and middle-income countries.
Journal
Journal of global health
ISSN: 2047-2986
Titre abrégé: J Glob Health
Pays: Scotland
ID NLM: 101578780
Informations de publication
Date de publication:
2022
2022
Historique:
entrez:
27
4
2022
pubmed:
28
4
2022
medline:
29
4
2022
Statut:
epublish
Résumé
The COVID-19 pandemic has caused disruptions to the functioning of societies and their health systems. Prior to the pandemic, health systems in low- and middle-income countries (LMIC) were particularly stretched and vulnerable. The International Society of Global Health (ISoGH) sought to systematically identify priorities for health research that would have the potential to reduce the impact of the COVID-19 pandemic in LMICs. The Child Health and Nutrition Research Initiative (CHNRI) method was used to identify COVID-19-related research priorities. All ISoGH members were invited to participate. Seventy-nine experts in clinical, translational, and population research contributed 192 research questions for consideration. Fifty-two experts then scored those questions based on five pre-defined criteria that were selected for this exercise: 1) feasibility and answerability; 2) potential for burden reduction; 3) potential for a paradigm shift; 4) potential for translation and implementation; and 5) impact on equity. Among the top 10 research priorities, research questions related to vaccination were prominent: health care system access barriers to equitable uptake of COVID-19 vaccination (ranked 1st), determinants of vaccine hesitancy (4th), development and evaluation of effective interventions to decrease vaccine hesitancy (5th), and vaccination impacts on vulnerable population/s (6th). Health care delivery questions also ranked highly, including: effective strategies to manage COVID-19 globally and in LMICs (2nd) and integrating health care for COVID-19 with other essential health services in LMICs (3rd). Additionally, the assessment of COVID-19 patients' needs in rural areas of LMICs was ranked 7th, and studying the leading socioeconomic determinants and consequences of the COVID-19 pandemic in LMICs using multi-faceted approaches was ranked 8th. The remaining questions in the top 10 were: clarifying paediatric case-fatality rates (CFR) in LMICs and identifying effective strategies for community engagement against COVID-19 in different LMIC contexts. Health policy and systems research to inform COVID-19 vaccine uptake and equitable access to care are urgently needed, especially for rural, vulnerable, and/or marginalised populations. This research should occur in parallel with studies that will identify approaches to minimise vaccine hesitancy and effectively integrate care for COVID-19 with other essential health services in LMICs. ISoGH calls on the funders of health research in LMICs to consider the urgency and priority of this research during the COVID-19 pandemic and support studies that could make a positive difference for the populations of LMICs.
Sections du résumé
Background
UNASSIGNED
The COVID-19 pandemic has caused disruptions to the functioning of societies and their health systems. Prior to the pandemic, health systems in low- and middle-income countries (LMIC) were particularly stretched and vulnerable. The International Society of Global Health (ISoGH) sought to systematically identify priorities for health research that would have the potential to reduce the impact of the COVID-19 pandemic in LMICs.
Methods
UNASSIGNED
The Child Health and Nutrition Research Initiative (CHNRI) method was used to identify COVID-19-related research priorities. All ISoGH members were invited to participate. Seventy-nine experts in clinical, translational, and population research contributed 192 research questions for consideration. Fifty-two experts then scored those questions based on five pre-defined criteria that were selected for this exercise: 1) feasibility and answerability; 2) potential for burden reduction; 3) potential for a paradigm shift; 4) potential for translation and implementation; and 5) impact on equity.
Results
UNASSIGNED
Among the top 10 research priorities, research questions related to vaccination were prominent: health care system access barriers to equitable uptake of COVID-19 vaccination (ranked 1st), determinants of vaccine hesitancy (4th), development and evaluation of effective interventions to decrease vaccine hesitancy (5th), and vaccination impacts on vulnerable population/s (6th). Health care delivery questions also ranked highly, including: effective strategies to manage COVID-19 globally and in LMICs (2nd) and integrating health care for COVID-19 with other essential health services in LMICs (3rd). Additionally, the assessment of COVID-19 patients' needs in rural areas of LMICs was ranked 7th, and studying the leading socioeconomic determinants and consequences of the COVID-19 pandemic in LMICs using multi-faceted approaches was ranked 8th. The remaining questions in the top 10 were: clarifying paediatric case-fatality rates (CFR) in LMICs and identifying effective strategies for community engagement against COVID-19 in different LMIC contexts.
Interpretation
UNASSIGNED
Health policy and systems research to inform COVID-19 vaccine uptake and equitable access to care are urgently needed, especially for rural, vulnerable, and/or marginalised populations. This research should occur in parallel with studies that will identify approaches to minimise vaccine hesitancy and effectively integrate care for COVID-19 with other essential health services in LMICs. ISoGH calls on the funders of health research in LMICs to consider the urgency and priority of this research during the COVID-19 pandemic and support studies that could make a positive difference for the populations of LMICs.
Identifiants
pubmed: 35475006
doi: 10.7189/jogh.12.09003
pii: jogh-12-09003
pmc: PMC9010705
doi:
Substances chimiques
COVID-19 Vaccines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
09003Subventions
Organisme : World Health Organization
ID : 001
Pays : International
Informations de copyright
Copyright © 2022 by the Journal of Global Health. All rights reserved.
Déclaration de conflit d'intérêts
Competing interests: Ana Marušić, Harry Campbell and Igor Rudan are the Co-Editors in Chief of the Journal of Global Health. To ensure that any possible conflict of interest relevant to the journal has been addressed, this article was reviewed according to best practice guidelines of international editorial organisations. The authors completed the ICMJE Unified Competing Interests Form (available upon request from the corresponding author) and declare no further conflicts of interest.
Références
J Glob Health. 2021 Nov 20;11:04071
pubmed: 34912548
Croat Med J. 2008 Dec;49(6):720-33
pubmed: 19090596
J Glob Health. 2016 Jun;6(1):010301
pubmed: 26401269
PLoS One. 2021 Sep 24;16(9):e0257516
pubmed: 34559827
J Glob Health. 2016 Jun;6(1):010503
pubmed: 27350874
J Glob Health. 2021 Nov 20;11:05027
pubmed: 34912550
J Glob Health. 2016 Jun;6(1):010507
pubmed: 26401271
J Glob Health. 2016 Jun;6(1):010303
pubmed: 27303649
J Glob Health. 2016 Jun;6(1):010501
pubmed: 27418959
Midwifery. 2021 Apr;95:102922
pubmed: 33515973
Lancet. 2021 Oct 2;398(10307):1212-1213
pubmed: 34600618
Am J Respir Crit Care Med. 2021 Feb 1;203(3):287-295
pubmed: 33522881
JAMA. 2014 Nov 12;312(18):1859-60
pubmed: 25285459
BMJ Glob Health. 2020 Jul;5(7):
pubmed: 32727843
J Glob Health. 2016 Jun;6(1):010302
pubmed: 27350870
Vaccines (Basel). 2019 Oct 18;7(4):
pubmed: 31635270
Wellcome Open Res. 2020 Sep 8;5:209
pubmed: 33117894
Lancet Glob Health. 2022 Apr;10(4):e570-e573
pubmed: 35303466
J Glob Health. 2016 Jun;6(1):010502
pubmed: 27350873
Nat Med. 2021 Aug;27(8):1385-1394
pubmed: 34272499
Vaccine. 2021 Oct 22;39(44):6539-6544
pubmed: 34598823
BMJ Open. 2021 Oct 27;11(10):e052135
pubmed: 34706957
Lancet. 2020 Aug 8;396(10248):375
pubmed: 32682490
Nature. 2022 Mar;603(7902):679-686
pubmed: 35042229
J Glob Health. 2021 Oct 09;11:15003
pubmed: 34737870
Expert Rev Vaccines. 2022 Jan;21(1):25-36
pubmed: 34758678
PLoS One. 2021 Aug 12;16(8):e0256099
pubmed: 34383861
PLoS One. 2021 Nov 29;16(11):e0260672
pubmed: 34843594
J Glob Health. 2017 Jun;7(1):011004
pubmed: 28685049
AAS Open Res. 2020 Nov 24;3:56
pubmed: 33709054
Lancet Respir Med. 2021 Dec;9(12):1467-1478
pubmed: 34416191